News

STEM Clinical Trial

STEM Clinical Trial

Balt today announced the presentation of preliminary data from The Squid Trial for the Embolization of the Middle meningeal artery (STEM) for the treatment of chronic Sub-Dural Hematoma during the late-breaking session at the International Stroke Conference in Phoenix, AZ. The preliminary data demonstrates that rates of complications thus far are low and embolizing the MMA for the treatment of Chronic Subdural Hematoma (cSDH) potentially improves the success rates of both surgical and non-surgical treatments.

 

Discover the press release

Other News

News
Jun 13, 2024

Balt in the news

Read More
Balt
News
May 30, 2024

French Government awards €4.2millon for an innovative treatment of hemorrhagic stroke, to be developed by Balt

Read More
French Government awards €4.2millon for an innovative treatment of hemorrhagic stroke, to be developed by Balt
News
Apr 17, 2024

Official visit at our Irvine (California) site

Read More
Official visit at our Irvine (California) site
News
Jan 09, 2024

BALT in the spotlight: media recognition for our stroke research work

Read More
BALT in the spotlight: media recognition for our stroke research work
News
Oct 10, 2023

Florence Leroy joins Balt’s Executive Team as VP Global Human Resources

Read More
Florence Leroy joins Balt’s Executive Team as VP Global Human Resources
News
Oct 08, 2023

Balt at the 20km of Paris

Read More
Balt at the 20km of Paris
Previous Next
Close
Balt Lab

Contact Us

Need more information? We are here to help.

EN